
The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.
Lawrence X. Yu is deputy director for science in the Office of Generic Drugs (OGD) at the US Food and Drug Administration, 7519 Standish Place, Rockville, MD 20855.

The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.

Published: October 2nd 2009 | Updated: